Analysis of highly conserved regions of the 3′UTR of MECP2 gene in patients with clinical diagnosis of Rett syndrome and other disorders associated with mental retardation

Disease Markers

Volumn 24, Issue 6, 2008, Pages 319-324

  Santos, Mónica ^a,b   Yan, Jin ^c   Temudo, Teresa ^d   Oliveira, Guiomar ^e   Vieira, José Pedro ^f   Fen, Jinong ^c   Sommer, Steve ^c   Maciel, Patrícia ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^e CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^f HOSPITAL FERNANDO FONSECA   (Portugal)

Author keywords

3 untranslated region; Autism; Neurodevelopment

Indexed keywords

NUCLEOTIDE;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC CONSERVATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MECP2 GENE; MENTAL DEFICIENCY; MUTATIONAL ANALYSIS; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RETT SYNDROME;

EID: 49149086853     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/738401     Document Type: Article

References (29)

1. R.E. Amir, I.B. Van den Veyver, M. Wan, C.Q. Tran, U. Francke and H.Y. Zoghbi, Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2, Nat Genet 23 (1999), 185-188.
2. C.L. Bennett, M.E. Brunkow, F. Ramsdell, K.C. O'Briant, Q. Zhu, R.L. Fuleihan, A.O. Shigeoka, H.D. Ochs and P.F. Chance, A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA->AAUGAA) leads to the IPEX syndrome, Immunogenetics 53 (2001), 435-439.
3. C.L. Bennett, J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, L. Whitesell, T.E. Kelly, F.T. Saulsbury, P.F. Chance and H.D. Ochs, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nat Genet 27 (2001), 20-21.
4. V. Bourdon, C. Philippe, O. Labrune, D. Amsallem, C. Arnould and P. Jonveaux, A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients, Hum Genet 108 (2001), 43-50.
5. C.R. Bramham and E. Messaoudi, BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis, Prog Neurobiol 76 (2005), 99-125.
6. J.M. Chen, C. Ferec and D.N. Cooper, Asystematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview, Hum Genet 120 (2006), 1-21.
7. B. Conne, A. Stutz and J.D. Vassalli, The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med 6 (2000), 637-641.
8. A.M. Coutinho, G. Oliveira, C. Katz, J. Feng, J. Yan, C. Yang, C. Marques, A. Ataide, T.S. Miguel, L. Borges, J. Almeida, C. Correia, A. Currais, C. Bento, L. Mota-Vieira, T. Temudo, M. Santos, P. Maciel, S.S. Sommer and A.M. Vicente, MECP2 coding sequence and 3′UTR variation in 172 unrelated autistic patients, Am J Med Genet B Neuropsychiatr Genet 144 (2007), 475-483.
9. J.F. Coy, Z. Sedlacek, D. Bachner, H. Delius and A. Poustka, A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3″-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression, Hum Mol Genet 8 (1999), 1253-1262.
10. M. D'Esposito, N.A. Quaderi, A. Ciccodicola, P. Bruni, T. Esposito, M. D'Urso and S.D. Brown, Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2, Mamm Genome 7 (1996), 533-535.
11. W.G. Fairbrother, R.F. Yeh, P.A. Sharp and C.B. Burge, Predictive identification of exonic splicing enhancers in human genes, Science 297 (2002), 1007-1013.
12. Y.H. Fu, A. Pizzuti, R.G. Fenwick, Jr., J. King, S. Rajnarayan, P.W. Dunne, J. Dubel, G.A. Nasser, T. Ashizawa, P. de Jong et al., An unstable triplet repeat in a gene related to myotonic muscular dystrophy, Science 255 (1992), 1256-1258.
13. A. Goren, O. Ram, M. Amit, H. Keren, G. Lev-Maor, I. Vig, T. Pupko and G. Ast, Comparative analysis identifies exonic splicing regulatory sequences - The complex definition of enhancers and silencers, Mol Cell 22 (2006), 769-781.
14. S.P. Gregorio, F.B. Mury, E.B. Ojopi, P.C. Sallet, D.H. Moreno, J. Yacubian, H. Tavares, F.R. Santos, W.F. Gattaz and E. Dias-Neto, Nogo CAA 3′UTR Insertion polymorphism is not associated with Schizophrenia nor with bipolar disorder, Schizophr Res 75 (2005), 5-9.
15. B. Hagberg, J. Aicardi, K. Dias and O. Ramos, A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases, Ann Neurol 14 (1983), 471-479.
16. B. Hagberg, F. Hanefeld, A. Percy and O. Skjeldal, An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001, Eur J Paediatr Neurol 6 (2002), 293-297.
17. E. Kondo-Iida, K. Kobayashi, M. Watanabe, J. Sasaki, T. Kumagai, H. Koide, K. Saito, M. Osawa, Y. Nakamura and T. Toda, Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD), Hum Mol Genet 8 (1999), 2303-2309.
18. Q. Liu, J. Feng, C. Buzin, C. Wen, G. Nozari, A. Mengos, V. Nguyen, J. Liu, L. Crawford, F.K. Fujimura and S.S. Sommer, Detection of virtually all mutations-SSCP (DOVAM-S): a rapid method for mutation scanning with virtually 100% sensitivity, Biotechniques 26 (1999), 932, 936-938, 940-932.
19. A.K. Percy, Rett syndrome: clinical correlates of the newly discovered gene, Brain Dev 23(Suppl 1) (2001), S202-S205.
20. L.P. Ranum and J.W. Day, Myotonic dystrophy: RNA pathogenesis comes into focus, Am J Hum Genet 74 (2004), 793-804.
21. K. Reichwald, J. Thiesen, T. Wiehe, J. Weitzel, W.A. Poustka, A. Rosenthal, M. Platzer, W.H. Stratling and P. Kioschis, Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions, Mamm Genome 11 (2000), 182-190.
22. J. Shi, A. Shibayama, Q. Liu, V.Q. Nguyen, J. Feng, M. Santos, T. Temudo, P. Maciel and S.S. Sommer, Detection of heterozygous deletions and duplications in the MECP2 gene in Rett syndrome by Robust Dosage PCR (RD-PCR), Hum Mutat 25 (2005), 505.
23. A. Shibayama, E.H. Cook, Jr., J. Feng, C. Glanzmann, J. Yan, N. Craddock, I.R. Jones, D. Goldman, L.L. Heston and S.S. Sommer, MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism, Am J Med Genet B Neuropsychiatr Genet 128 (2004), 50-53.
24. M. Venturin, S. Moncini, V. Villa, S. Russo, M.T. Bonati, L. Larizza and P. Riva, Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with non-syndromic mental retardation, Neurogenetics 7 (2006), 59-66.
25. R. Vidal, T. Revesz, A. Rostagno, E. Kim, J.L. Holton, T. Bek, M. Bojsen-Moller, H. Braendgaard, G. Plant, J. Ghiso and B. Frangione, A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred, Proc Natl Acad Sci USA 97 (2000), 4920-4925.
26. Z. Wang, M.E. Rolish, G. Yeo, V. Tung, M. Mawson and C.B. Burge, Systematic identification and analysis of exonic splicing silencers, Cell 119 (2004), 831-845.
27. B.G. Weinshenker, D.D. Hebrink, C. Klein, E.J. Atkinson, P.C. O'Brien and C.T. McMurray, Genetic variation in the B7-1 gene in patients with multiple sclerosis, J Neuroimmunol 105 (2000), 184-188.
28. D.G. Wells, X. Dong, E.M. Quinlan, Y.S. Huang, M.F. Bear, J.D. Richter and J.R. Fallon, A role for the cytoplasmic polyadenylation element in NMDA receptor-regulated mRNA translation in neurons, J Neurosci 21 (2001), 9541-9548.
29. X.H. Zhang and L.A. Chasin, Computational definition of sequence motifs governing constitutive exon splicing, Genes Dev 18 (2004), 1241-1250.